Cargando…
lncRNA VIM-AS1 acts as a prognostic biomarker and promotes apoptosis in lung adenocarcinoma
Background: Long non-coding RNA VIM-antisense 1 (VIM-AS1) has been reported that it is involved in the progression of several cancers. However, the aberrant expression profile, clinical significance, and biological function of VIM-AS1in lung adenocarcinoma (LUAD) have not been fully described. We te...
Autores principales: | Kang, Jianhong, Abudurufu, Maimaiti, Zhang, Shuwei, Jiang, Wei, Luo, Honghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240666/ https://www.ncbi.nlm.nih.gov/pubmed/37283796 http://dx.doi.org/10.7150/jca.83639 |
Ejemplares similares
-
Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma
por: Shi, Xiuhui, et al.
Publicado: (2018) -
Discovered differentially expressed lncRNA AC010973.2 can act as a diagnostic and prognostic biomarker for colon adenocarcinoma
por: Liu, Xinhong, et al.
Publicado: (2020) -
LncRNA-AC068228.1 Is a Novel Prognostic Biomarker That Promotes Malignant Phenotypes in Lung Adenocarcinoma
por: Jiang, Xiulin, et al.
Publicado: (2022) -
The novel lncRNA p4516 acts as a prognostic biomarker promoting gastric cancer cell proliferation and metastasis
por: Nie, Meng-Lin, et al.
Publicado: (2019) -
LncRNA SUMO1P3 acts as a prognostic biomarker and promotes hepatocellular carcinoma growth and metastasis
por: Hu, Shu, et al.
Publicado: (2021)